Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
21.76%
↑ 162% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-35.25%
Historical baseline
PeriodValue
202521.76%
2024-4.38%
2023-5.54%
2022-3.35%
2021-96.20%
2020-106.49%
2019-87.81%
20180.00%